ID   GALNS_HUMAN             Reviewed;         522 AA.
AC   P34059; Q86VK3;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   10-MAY-2017, entry version 170.
DE   RecName: Full=N-acetylgalactosamine-6-sulfatase;
DE            EC=3.1.6.4;
DE   AltName: Full=Chondroitinsulfatase;
DE            Short=Chondroitinase;
DE   AltName: Full=Galactose-6-sulfate sulfatase;
DE            Short=GalN6S;
DE   AltName: Full=N-acetylgalactosamine-6-sulfate sulfatase;
DE            Short=GalNAc6S sulfatase;
DE   Flags: Precursor;
GN   Name=GALNS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Placenta;
RX   PubMed=1755850; DOI=10.1016/0006-291X(91)91244-7;
RA   Tomatsu S., Fukuda S., Masue M., Sukegawa K., Fukao T., Yamagishi A.,
RA   Hori T., Iwata H., Ogawa T., Nakashima Y., Hanyu Y., Hashimoto T.,
RA   Titani K., Oyama R., Suzuki M., Yagi K., Hayashi Y., Orii T.;
RT   "Morquio disease: isolation, characterization and expression of full-
RT   length cDNA for human N-acetylgalactosamine-6-sulfate sulfatase.";
RL   Biochem. Biophys. Res. Commun. 181:677-683(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8001980; DOI=10.1006/geno.1994.1443;
RA   Morris C.P., Guo X.H., Apostolou S., Hopwood J.J., Scott H.S.;
RT   "Morquio A syndrome: cloning, sequence, and structure of the human N-
RT   acetylgalactosamine 6-sulfatase (GALNS) gene.";
RL   Genomics 22:652-654(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-423.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 27-522, GLYCOSYLATION AT
RP   ASN-204 AND ASN-423, OXOALANINE AT CYS-79, SUBUNIT, COFACTOR,
RP   CATALYTIC ACTIVITY, CALCIUM-BINDING SITES, AND DISULFIDE BONDS.
RX   PubMed=22940367; DOI=10.1016/j.jmb.2012.08.020;
RA   Rivera-Colon Y., Schutsky E.K., Kita A.Z., Garman S.C.;
RT   "The structure of human GALNS reveals the molecular basis for
RT   mucopolysaccharidosis IV A.";
RL   J. Mol. Biol. 423:736-751(2012).
RN   [7]
RP   INVOLVEMENT IN MPS4A, AND VARIANT MPS4A LYS-204.
RX   PubMed=1522213; DOI=10.1172/JCI115919;
RA   Fukuda S., Tomatsu S., Masue M., Sukegawa K., Iwata H., Ogawa T.,
RA   Nakashima Y., Hori T., Yamagishi A., Hanyu Y., Morooka K., Kiman T.,
RA   Hashimoto T., Orii T.;
RT   "Mucopolysaccharidosis type IVA. N-acetylgalactosamine-6-sulfate
RT   sulfatase exonic point mutations in classical Morquio and mild
RT   cases.";
RL   J. Clin. Invest. 90:1049-1053(1992).
RN   [8]
RP   VARIANTS MPS4A ARG-77; TRP-90; VAL-96; PHE-113; LEU-151; GLY-230;
RP   THR-291; CYS-386 AND SER-487.
RX   PubMed=7668283;
RA   Tomatsu S., Fukuda S., Cooper A., Wraith J.E., Maruf Rezvi G.,
RA   Yamagishi A., Yamada N., Kato Z., Isogai K., Sukegawa K., Kondo N.,
RA   Suzuki Y., Shimozawa N., Orii T.;
RT   "Mucopolysaccharidosis IVA: identification of a common missense
RT   mutation I113F in the N-Acetylgalactosamine-6-sulfate sulfatase
RT   gene.";
RL   Am. J. Hum. Genet. 57:556-563(1995).
RN   [9]
RP   VARIANTS MPS4A.
RX   PubMed=7795586; DOI=10.1093/hmg/4.3.341;
RA   Ogawa T., Tomatsu S., Fukuda S., Yamagishi A., Maruf Rezvi G.,
RA   Sukegawa K., Kondo N., Suzuki Y., Shimozawa N., Orii T.;
RT   "Mucopolysaccharidosis IVA: screening and identification of mutations
RT   of the N-acetylgalactosamine-6-sulfate sulfatase gene.";
RL   Hum. Mol. Genet. 4:341-349(1995).
RN   [10]
RP   VARIANTS MPS4A ARG-77; TRP-90; VAL-96; LEU-151; GLY-230 AND THR-291.
RX   PubMed=7633425; DOI=10.1093/hmg/4.4.741;
RA   Tomatsu S., Fukuda S., Cooper A., Wraith J.E., Maruf Rezvi G.,
RA   Yamagishi A., Yamada N., Kato Z., Isogai K., Sukegawa K., Kondo N.,
RA   Suzuki Y., Shimozawa N., Orii T.;
RT   "Mucopolysaccharidosis type IVA: identification of six novel mutations
RT   among non-Japanese patients.";
RL   Hum. Mol. Genet. 4:741-743(1995).
RN   [11]
RP   VARIANT MPS4A SER-487.
RX   PubMed=7581409; DOI=10.1002/humu.1380060218;
RA   Tomatsu S., Fukuda S., Cooper A., Wraith J.E., Yamada N., Isogai K.,
RA   Kato Z., Sukegawa K., Kondo N., Suzuki Y., Shimozawa N., Orii T.;
RT   "Two new mutations, Q473X and N487S, in a Caucasian patient with
RT   mucopolysaccharidosis IVA (Morquio disease).";
RL   Hum. Mutat. 6:195-196(1995).
RN   [12]
RP   VARIANTS MPS4A ALA-138; SER-151 AND LEU-151.
RX   PubMed=8651279;
RA   Tomatsu S., Fukuda S., Yamagishi A., Cooper A., Wraith J.E., Hori T.,
RA   Kato Z., Yamada N., Isogai K., Sukegawa K., Kondo N., Suzuki Y.,
RA   Shimozawa N., Orii T.;
RT   "Mucopolysaccharidosis IVA: four new exonic mutations in patients with
RT   N-acetylgalactosamine-6-sulfate sulfatase deficiency.";
RL   Am. J. Hum. Genet. 58:950-962(1996).
RN   [13]
RP   VARIANTS MPS4A CYS-94 AND VAL-97.
RX   PubMed=8826435;
RX   DOI=10.1002/(SICI)1096-8628(19960628)63:4<558::AID-AJMG9>3.3.CO;2-V;
RA   Cole D.E.C., Fukuda S., Gordon B.A., Rip J.W., Lecouteur A.N.,
RA   Rupar C.A., Tomatsu S., Ogawa T., Sukegawa K., Orii T.;
RT   "Heteroallelic missense mutations of the galactosamine-6-sulfate
RT   sulfatase (GALNS) gene in a mild form of Morquio disease (MPS IVA).";
RL   Am. J. Med. Genet. 63:558-565(1996).
RN   [14]
RP   VARIANTS MPS4A.
RX   PubMed=9298823;
RX   DOI=10.1002/(SICI)1098-1004(1997)10:3<223::AID-HUMU8>3.3.CO;2-M;
RA   Bunge S., Kleijer W.J., Tylki-Szymanska A., Steglich C., Beck M.,
RA   Tomatsu S., Fukuda S., Poorthuis B.J.H.M., Czartoryska B., Orii T.,
RA   Gal A.;
RT   "Identification of 31 novel mutations in the N-acetylgalactosamine-6-
RT   sulfatase gene reveals excessive allelic heterogeneity among patients
RT   with Morquio A syndrome.";
RL   Hum. Mutat. 10:223-232(1997).
RN   [15]
RP   VARIANTS MPS4A LEU-80; CYS-94; VAL-97; LEU-125; SER-139; GLN-166;
RP   GLY-185; SER-290; ARG-309; VAL-351; CYS-386; VAL-391 AND PRO-395.
RX   PubMed=9375852;
RX   DOI=10.1002/(SICI)1098-1004(1997)10:5<368::AID-HUMU6>3.0.CO;2-B;
RA   Tomatsu S., Fukuda S., Cooper A., Wraith J.E., Ferreira P.,
RA   di Natale P., Tortora P., Fujimoto A., Kato Z., Yamada N., Isogai K.,
RA   Yamagishi A., Sukegawa K., Suzuki Y., Shimozawa N., Kondo N.,
RA   Sly W.S., Orii T.;
RT   "Fourteen novel mucopolysaccharidosis IVA producing mutations in GALNS
RT   gene.";
RL   Hum. Mutat. 10:368-375(1997).
RN   [16]
RP   VARIANTS MPS4A VAL-96; PHE-113; ARG-135; CYS-156; LEU-179; THR-257;
RP   VAL-284; SER-312; GLN-376 AND VAL-395.
RX   PubMed=9521421;
RX   DOI=10.1002/(SICI)1098-1004(1998)11:3<202::AID-HUMU4>3.0.CO;2-J;
RA   Yamada N., Fukuda S., Tomatsu S., Muller V., Hopwood J.J., Nelson J.,
RA   Kato Z., Yamagishi A., Sukegawa K., Kondo N., Orii T.;
RT   "Molecular heterogeneity in mucopolysaccharidosis IVA in Australia and
RT   Northern Ireland: nine novel mutations including T312S, a common
RT   allele that confers a mild phenotype.";
RL   Hum. Mutat. 11:202-208(1998).
RN   [17]
RP   VARIANTS SER-393 AND MET-488.
RX   PubMed=9452036;
RA   Tomatsu S., Fukuda S., Cooper A., Wraith J.E., Yamagishi A., Kato Z.,
RA   Yamada N., Isogai K., Sukegawa K., Suzuki Y., Shimozawa N., Kondo N.,
RA   Orii T.;
RT   "Fifteen polymorphisms in the N-acetylgalactosamine-6-sulfate
RT   sulfatase (GALNS) gene: diagnostic implications in Morquio disease.";
RL   Hum. Mutat. Suppl. 1:S42-S46(1998).
RN   [18]
RP   VARIANTS MPS4A MET-15; 17-LEU-SER-18 DEL; ARG-23; PRO-36; LEU-41;
RP   GLU-42; 52-PRO--GLU-55 DEL; PHE-53; TRP-61; VAL-69; 71-ASN--SER-74
RP   DELINS THR; TYR-79; LEU-94; THR-107; SER-116; CYS-141; TYR-150;
RP   GLU-155; PHE-162; THR-164; VAL-167; ALA-171; SER-179; VAL-203;
RP   ASN-233; PHE-239; TRP-253; ASP-260; PHE-285 DEL; PRO-307; ASN-310;
RP   CYS-325; ASP-340; ARG-341; PRO-345; PRO-352; LEU-357; PRO-369;
RP   THR-380; SER-380; HIS-386; ASN-388; VAL-392; ASP-398; TYR-401;
RP   403-TRP-THR-404 DEL; ILE-452; PRO-470 AND SER-484, AND VARIANTS
RP   MET-67; VAL-178; MET-200; GLY-231; SER-393; VAL-459 AND MET-488.
RX   PubMed=16287098; DOI=10.1002/humu.20257;
RA   Tomatsu S., Montano A.M., Nishioka T., Gutierrez M.A., Pena O.M.,
RA   Tranda Firescu G.G., Lopez P., Yamaguchi S., Noguchi A., Orii T.;
RT   "Mutation and polymorphism spectrum of the GALNS gene in
RT   mucopolysaccharidosis IVA (Morquio A).";
RL   Hum. Mutat. 26:500-512(2005).
RN   [19]
RP   VARIANTS [LARGE SCALE ANALYSIS] TRP-61 AND THR-510.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [20]
RP   VARIANTS MPS4A GLU-16; ARG-36; ASN-40; GLY-48; LYS-51; ARG-77; LEU-80;
RP   LEU-81; GLU-84; TRP-90; PRO-91; CYS-94; LEU-94; PHE-113; VAL-116;
RP   SER-116; SER-139; ARG-141; TYR-145; LEU-151; ARG-155; LEU-156;
RP   ARG-166; SER-179; GLU-201; PRO-214; SER-216; GLY-230; ASN-233;
RP   LYS-235; THR-264; LEU-287; THR-291; CYS-301; SER-312; ARG-318;
RP   LEU-357; GLY-380; THR-380; CYS-386; HIS-386; VAL-391; VAL-392;
RP   HIS-407; VAL-415; THR-416; ARG-420; THR-492; VAL-494; SER-500 AND
RP   PHE-507, VARIANTS PHE-74; ASP-121; CYS-159; TYR-165; GLN-251; CYS-254;
RP   LYS-260 AND LYS-495, AND CHARACTERIZATION OF VARIANTS MPS4A GLU-16;
RP   ARG-36; LYS-51; LEU-81; GLU-84; PRO-91; VAL-116; TYR-145; LEU-156;
RP   ARG-166; GLU-201; PRO-214; SER-216; THR-264; GLY-380; VAL-415;
RP   THR-416; ARG-420; THR-492 AND SER-500.
RX   PubMed=24726177; DOI=10.1016/j.ymgme.2014.03.004;
RA   Morrone A., Tylee K.L., Al-Sayed M., Brusius-Facchin A.C.,
RA   Caciotti A., Church H.J., Coll M.J., Davidson K., Fietz M.J., Gort L.,
RA   Hegde M., Kubaski F., Lacerda L., Laranjeira F., Leistner-Segal S.,
RA   Mooney S., Pajares S., Pollard L., Ribeiro I., Wang R.Y., Miller N.;
RT   "Molecular testing of 163 patients with Morquio A
RT   (Mucopolysaccharidosis IVA) identifies 39 novel GALNS mutations.";
RL   Mol. Genet. Metab. 112:160-170(2014).
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of the 6-sulfate groups of the N-
CC       acetyl-D-galactosamine 6-sulfate units of chondroitin sulfate and
CC       of the D-galactose 6-sulfate units of keratan sulfate.
CC       {ECO:0000269|PubMed:22940367}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:22940367};
CC       Note=Binds 1 Ca(2+) ion per subunit.
CC       {ECO:0000269|PubMed:22940367};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:22940367}.
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- PTM: The conversion to 3-oxoalanine (also known as C-
CC       formylglycine, FGly), of a serine or cysteine residue in
CC       prokaryotes and of a cysteine residue in eukaryotes, is critical
CC       for catalytic activity. {ECO:0000269|PubMed:22940367}.
CC   -!- DISEASE: Mucopolysaccharidosis 4A (MPS4A) [MIM:253000]: A form of
CC       mucopolysaccharidosis type 4, an autosomal recessive lysosomal
CC       storage disease characterized by intracellular accumulation of
CC       keratan sulfate and chondroitin-6-sulfate. Key clinical features
CC       include short stature, skeletal dysplasia, dental anomalies, and
CC       corneal clouding. Intelligence is normal and there is no direct
CC       central nervous system involvement, although the skeletal changes
CC       may result in neurologic complications. There is variable
CC       severity, but patients with the severe phenotype usually do not
CC       survive past the second or third decade of life.
CC       {ECO:0000269|PubMed:1522213, ECO:0000269|PubMed:16287098,
CC       ECO:0000269|PubMed:24726177, ECO:0000269|PubMed:7581409,
CC       ECO:0000269|PubMed:7633425, ECO:0000269|PubMed:7668283,
CC       ECO:0000269|PubMed:7795586, ECO:0000269|PubMed:8651279,
CC       ECO:0000269|PubMed:8826435, ECO:0000269|PubMed:9298823,
CC       ECO:0000269|PubMed:9375852, ECO:0000269|PubMed:9521421}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the sulfatase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D17629; BAA04535.1; -; Genomic_DNA.
DR   EMBL; U06088; AAC51350.1; -; Genomic_DNA.
DR   EMBL; U06078; AAC51350.1; JOINED; Genomic_DNA.
DR   EMBL; U06079; AAC51350.1; JOINED; Genomic_DNA.
DR   EMBL; U06080; AAC51350.1; JOINED; Genomic_DNA.
DR   EMBL; U06081; AAC51350.1; JOINED; Genomic_DNA.
DR   EMBL; U06082; AAC51350.1; JOINED; Genomic_DNA.
DR   EMBL; U06083; AAC51350.1; JOINED; Genomic_DNA.
DR   EMBL; U06084; AAC51350.1; JOINED; Genomic_DNA.
DR   EMBL; U06085; AAC51350.1; JOINED; Genomic_DNA.
DR   EMBL; U06086; AAC51350.1; JOINED; Genomic_DNA.
DR   EMBL; U06087; AAC51350.1; JOINED; Genomic_DNA.
DR   EMBL; BC050684; AAH50684.2; -; mRNA.
DR   EMBL; BC056151; AAH56151.1; -; mRNA.
DR   CCDS; CCDS10970.1; -.
DR   PIR; JQ1299; KJHUG6.
DR   RefSeq; NP_000503.1; NM_000512.4.
DR   UniGene; Hs.271383; -.
DR   PDB; 4FDI; X-ray; 2.20 A; A/B=27-522.
DR   PDB; 4FDJ; X-ray; 2.81 A; A/B=27-522.
DR   PDBsum; 4FDI; -.
DR   PDBsum; 4FDJ; -.
DR   ProteinModelPortal; P34059; -.
DR   SMR; P34059; -.
DR   BioGrid; 108860; 29.
DR   IntAct; P34059; 1.
DR   STRING; 9606.ENSP00000268695; -.
DR   DrugBank; DB09051; Elosulfase alfa.
DR   iPTMnet; P34059; -.
DR   PhosphoSitePlus; P34059; -.
DR   BioMuta; GALNS; -.
DR   DMDM; 462148; -.
DR   EPD; P34059; -.
DR   MaxQB; P34059; -.
DR   PaxDb; P34059; -.
DR   PeptideAtlas; P34059; -.
DR   PRIDE; P34059; -.
DR   DNASU; 2588; -.
DR   Ensembl; ENST00000268695; ENSP00000268695; ENSG00000141012.
DR   GeneID; 2588; -.
DR   KEGG; hsa:2588; -.
DR   UCSC; uc002fly.4; human.
DR   CTD; 2588; -.
DR   DisGeNET; 2588; -.
DR   GeneCards; GALNS; -.
DR   GeneReviews; GALNS; -.
DR   H-InvDB; HIX0134371; -.
DR   HGNC; HGNC:4122; GALNS.
DR   HPA; CAB026404; -.
DR   MalaCards; GALNS; -.
DR   MIM; 253000; phenotype.
DR   MIM; 612222; gene.
DR   neXtProt; NX_P34059; -.
DR   OpenTargets; ENSG00000141012; -.
DR   Orphanet; 309297; Mucopolysaccharidosis type 4A.
DR   PharmGKB; PA28535; -.
DR   eggNOG; KOG3867; Eukaryota.
DR   eggNOG; COG3119; LUCA.
DR   GeneTree; ENSGT00760000119062; -.
DR   HOGENOM; HOG000135352; -.
DR   HOVERGEN; HBG004283; -.
DR   InParanoid; P34059; -.
DR   KO; K01132; -.
DR   OMA; HFGPYNS; -.
DR   OrthoDB; EOG091G07AL; -.
DR   PhylomeDB; P34059; -.
DR   TreeFam; TF314186; -.
DR   BioCyc; MetaCyc:HS06790-MONOMER; -.
DR   BRENDA; 3.1.6.4; 2681.
DR   Reactome; R-HSA-2022857; Keratan sulfate degradation.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   ChiTaRS; GALNS; human.
DR   GeneWiki; Galactosamine-6_sulfatase; -.
DR   GenomeRNAi; 2588; -.
DR   PRO; PR:P34059; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000141012; -.
DR   CleanEx; HS_GALNS; -.
DR   ExpressionAtlas; P34059; baseline and differential.
DR   Genevisible; P34059; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003943; F:N-acetylgalactosamine-4-sulfatase activity; TAS:ProtInc.
DR   GO; GO:0043890; F:N-acetylgalactosamine-6-sulfatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008484; F:sulfuric ester hydrolase activity; IDA:MGI.
DR   GO; GO:0042340; P:keratan sulfate catabolic process; TAS:Reactome.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   Gene3D; 3.40.720.10; -; 2.
DR   InterPro; IPR017849; Alkaline_Pase-like_a/b/a.
DR   InterPro; IPR017850; Alkaline_phosphatase_core.
DR   InterPro; IPR024607; Sulfatase_CS.
DR   InterPro; IPR000917; Sulfatase_N.
DR   Pfam; PF00884; Sulfatase; 1.
DR   SUPFAM; SSF53649; SSF53649; 1.
DR   PROSITE; PS00523; SULFATASE_1; 1.
DR   PROSITE; PS00149; SULFATASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Complete proteome; Direct protein sequencing;
KW   Disease mutation; Disulfide bond; Dwarfism; Glycoprotein; Hydrolase;
KW   Lysosome; Metal-binding; Mucopolysaccharidosis; Polymorphism;
KW   Reference proteome; Signal.
FT   SIGNAL        1     26
FT   CHAIN        27    522       N-acetylgalactosamine-6-sulfatase.
FT                                /FTId=PRO_0000033411.
FT   REGION       27    379       Catalytic domain.
FT   METAL        39     39       Calcium. {ECO:0000269|PubMed:22940367}.
FT   METAL        40     40       Calcium. {ECO:0000269|PubMed:22940367}.
FT   METAL        79     79       Calcium; via 3-oxoalanine.
FT                                {ECO:0000269|PubMed:22940367}.
FT   METAL       288    288       Calcium. {ECO:0000269|PubMed:22940367}.
FT   METAL       289    289       Calcium. {ECO:0000269|PubMed:22940367}.
FT   MOD_RES      79     79       3-oxoalanine (Cys).
FT                                {ECO:0000269|PubMed:22940367}.
FT   CARBOHYD    204    204       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:22940367}.
FT   CARBOHYD    423    423       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:22940367}.
FT   DISULFID    308    419       {ECO:0000269|PubMed:22940367}.
FT   DISULFID    489    518       {ECO:0000269|PubMed:22940367}.
FT   DISULFID    501    507       {ECO:0000269|PubMed:22940367}.
FT   VARIANT      15     15       L -> M (in MPS4A; dbSNP:rs866745731).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024873.
FT   VARIANT      16     16       V -> E (in MPS4A; reduced enzymatic
FT                                activity; dbSNP:rs794729202).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071569.
FT   VARIANT      17     18       Missing (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024874.
FT   VARIANT      23     23       G -> R (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024875.
FT   VARIANT      36     36       L -> P (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024876.
FT   VARIANT      36     36       L -> R (in MPS4A; reduced enzymatic
FT                                activity; dbSNP:rs755832705).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071570.
FT   VARIANT      40     40       D -> N (in MPS4A).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071571.
FT   VARIANT      41     41       M -> L (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024877.
FT   VARIANT      42     42       G -> E (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024878.
FT   VARIANT      47     47       G -> R (in MPS4A; severe form;
FT                                dbSNP:rs199638097).
FT                                /FTId=VAR_007172.
FT   VARIANT      48     48       V -> G (in MPS4A; dbSNP:rs191519947).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071572.
FT   VARIANT      51     51       E -> K (in MPS4A; reduced enzymatic
FT                                activity). {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071573.
FT   VARIANT      52     55       Missing (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024879.
FT   VARIANT      53     53       S -> F (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024880.
FT   VARIANT      60     60       D -> N (in MPS4A; mild form;
FT                                dbSNP:rs118204447).
FT                                /FTId=VAR_007173.
FT   VARIANT      61     61       R -> W (in MPS4A; dbSNP:rs145798311).
FT                                {ECO:0000269|PubMed:16287098,
FT                                ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_024881.
FT   VARIANT      67     67       L -> M (associated with S-409 in a MPS4A
FT                                patient; dbSNP:rs11862754).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_007174.
FT   VARIANT      69     69       F -> V (in MPS4A; dbSNP:rs118204445).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024882.
FT   VARIANT      71     74       NFYS -> T (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024883.
FT   VARIANT      74     74       S -> F. {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071574.
FT   VARIANT      77     77       P -> R (in MPS4A; severe form).
FT                                {ECO:0000269|PubMed:24726177,
FT                                ECO:0000269|PubMed:7633425,
FT                                ECO:0000269|PubMed:7668283}.
FT                                /FTId=VAR_007175.
FT   VARIANT      79     79       C -> Y (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024884.
FT   VARIANT      80     80       S -> L (in MPS4A; intermediate form).
FT                                {ECO:0000269|PubMed:24726177,
FT                                ECO:0000269|PubMed:9375852}.
FT                                /FTId=VAR_007177.
FT   VARIANT      81     81       P -> L (in MPS4A; reduced enzymatic
FT                                activity). {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071575.
FT   VARIANT      84     84       A -> E (in MPS4A; loss of enzymatic
FT                                activity; dbSNP:rs141340188).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071576.
FT   VARIANT      90     90       R -> W (in MPS4A; severe form).
FT                                {ECO:0000269|PubMed:24726177,
FT                                ECO:0000269|PubMed:7633425,
FT                                ECO:0000269|PubMed:7668283}.
FT                                /FTId=VAR_007178.
FT   VARIANT      91     91       L -> P (in MPS4A; loss of enzymatic
FT                                activity). {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071577.
FT   VARIANT      94     94       R -> C (in MPS4A; mild/intermediate
FT                                form). {ECO:0000269|PubMed:24726177,
FT                                ECO:0000269|PubMed:8826435,
FT                                ECO:0000269|PubMed:9375852}.
FT                                /FTId=VAR_007179.
FT   VARIANT      94     94       R -> G (in MPS4A; mild/intermediate form;
FT                                dbSNP:rs118204441).
FT                                /FTId=VAR_007180.
FT   VARIANT      94     94       R -> L (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098,
FT                                ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_024885.
FT   VARIANT      96     96       G -> C (in MPS4A).
FT                                /FTId=VAR_007181.
FT   VARIANT      96     96       G -> V (in MPS4A; severe form).
FT                                {ECO:0000269|PubMed:7633425,
FT                                ECO:0000269|PubMed:7668283,
FT                                ECO:0000269|PubMed:9521421}.
FT                                /FTId=VAR_007182.
FT   VARIANT      97     97       F -> V (in MPS4A; mild form).
FT                                {ECO:0000269|PubMed:8826435,
FT                                ECO:0000269|PubMed:9375852}.
FT                                /FTId=VAR_007183.
FT   VARIANT     107    107       A -> T (in MPS4A; dbSNP:rs763184657).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024886.
FT   VARIANT     111    111       Q -> R (in MPS4A; intermediate form).
FT                                /FTId=VAR_007184.
FT   VARIANT     113    113       I -> F (in MPS4A; severe form; common
FT                                mutation; found in patients with Irish-
FT                                British ancestry; dbSNP:rs118204438).
FT                                {ECO:0000269|PubMed:24726177,
FT                                ECO:0000269|PubMed:7668283,
FT                                ECO:0000269|PubMed:9521421}.
FT                                /FTId=VAR_007185.
FT   VARIANT     116    116       G -> S (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098,
FT                                ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_024887.
FT   VARIANT     116    116       G -> V (in MPS4A; reduced enzymatic
FT                                activity). {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071578.
FT   VARIANT     121    121       E -> D. {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071579.
FT   VARIANT     125    125       P -> L (in MPS4A; severe form;
FT                                dbSNP:rs746949976).
FT                                {ECO:0000269|PubMed:9375852}.
FT                                /FTId=VAR_007186.
FT   VARIANT     135    135       S -> R (in MPS4A; severe form).
FT                                {ECO:0000269|PubMed:9521421}.
FT                                /FTId=VAR_007187.
FT   VARIANT     138    138       V -> A (in MPS4A; mild/severe/
FT                                intermediate form; dbSNP:rs118204436).
FT                                {ECO:0000269|PubMed:8651279}.
FT                                /FTId=VAR_007188.
FT   VARIANT     139    139       G -> S (in MPS4A; severe form;
FT                                dbSNP:rs146093755).
FT                                {ECO:0000269|PubMed:24726177,
FT                                ECO:0000269|PubMed:9375852}.
FT                                /FTId=VAR_007189.
FT   VARIANT     141    141       W -> C (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024888.
FT   VARIANT     141    141       W -> R (in MPS4A; severe form;
FT                                dbSNP:rs794727625).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_007190.
FT   VARIANT     145    145       H -> Y (in MPS4A; reduced enzymatic
FT                                activity; dbSNP:rs577334837).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071580.
FT   VARIANT     150    150       H -> Y (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024889.
FT   VARIANT     151    151       P -> L (in MPS4A; severe form;
FT                                dbSNP:rs559063128).
FT                                {ECO:0000269|PubMed:24726177,
FT                                ECO:0000269|PubMed:7633425,
FT                                ECO:0000269|PubMed:7668283,
FT                                ECO:0000269|PubMed:8651279}.
FT                                /FTId=VAR_007191.
FT   VARIANT     151    151       P -> S (in MPS4A; severe form).
FT                                {ECO:0000269|PubMed:8651279}.
FT                                /FTId=VAR_007192.
FT   VARIANT     155    155       G -> E (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024890.
FT   VARIANT     155    155       G -> R (in MPS4A; severe form;
FT                                dbSNP:rs398123438).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_007193.
FT   VARIANT     156    156       F -> C (in MPS4A; severe form).
FT                                {ECO:0000269|PubMed:9521421}.
FT                                /FTId=VAR_007194.
FT   VARIANT     156    156       F -> L (in MPS4A; reduced enzymatic
FT                                activity). {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071581.
FT   VARIANT     156    156       F -> S (in MPS4A; mild form).
FT                                /FTId=VAR_007195.
FT   VARIANT     159    159       W -> C. {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071582.
FT   VARIANT     162    162       S -> F (in MPS4A; dbSNP:rs118204444).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024891.
FT   VARIANT     164    164       N -> T (in MPS4A; dbSNP:rs761725425).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024892.
FT   VARIANT     165    165       C -> Y (in dbSNP:rs768757999).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071583.
FT   VARIANT     166    166       H -> Q (in MPS4A; severe form).
FT                                {ECO:0000269|PubMed:9375852}.
FT                                /FTId=VAR_007196.
FT   VARIANT     166    166       H -> R (in MPS4A; reduced enzymatic
FT                                activity). {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071584.
FT   VARIANT     167    167       F -> V (in MPS4A; dbSNP:rs148565559).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024893.
FT   VARIANT     168    168       G -> R (in MPS4A; dbSNP:rs775732598).
FT                                /FTId=VAR_007197.
FT   VARIANT     171    171       D -> A (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024894.
FT   VARIANT     178    178       I -> V. {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_007198.
FT   VARIANT     179    179       P -> H (in MPS4A; severe form).
FT                                /FTId=VAR_007199.
FT   VARIANT     179    179       P -> L (in MPS4A; severe form).
FT                                {ECO:0000269|PubMed:9521421}.
FT                                /FTId=VAR_007200.
FT   VARIANT     179    179       P -> S (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098,
FT                                ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_024895.
FT   VARIANT     185    185       E -> G (in MPS4A; severe form).
FT                                {ECO:0000269|PubMed:9375852}.
FT                                /FTId=VAR_007201.
FT   VARIANT     200    200       T -> M (in dbSNP:rs7187889).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_007202.
FT   VARIANT     201    201       G -> E (in MPS4A; reduced enzymatic
FT                                activity; dbSNP:rs772413313).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071585.
FT   VARIANT     203    203       A -> V (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024896.
FT   VARIANT     204    204       N -> K (in MPS4A; mild form;
FT                                dbSNP:rs118204435).
FT                                {ECO:0000269|PubMed:1522213}.
FT                                /FTId=VAR_007203.
FT   VARIANT     214    214       L -> P (in MPS4A; reduced enzymatic
FT                                activity; dbSNP:rs771810111).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071586.
FT   VARIANT     216    216       F -> S (in MPS4A; reduced enzymatic
FT                                activity; dbSNP:rs747805226).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071587.
FT   VARIANT     230    230       W -> G (in MPS4A; severe form).
FT                                {ECO:0000269|PubMed:24726177,
FT                                ECO:0000269|PubMed:7633425,
FT                                ECO:0000269|PubMed:7668283}.
FT                                /FTId=VAR_007204.
FT   VARIANT     231    231       A -> G (in dbSNP:rs34745339).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_007205.
FT   VARIANT     233    233       D -> N (in MPS4A; dbSNP:rs753051547).
FT                                {ECO:0000269|PubMed:16287098,
FT                                ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_024897.
FT   VARIANT     235    235       T -> K (in MPS4A; dbSNP:rs398123440).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071588.
FT   VARIANT     239    239       V -> F (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024898.
FT   VARIANT     247    247       G -> D (in MPS4A; dbSNP:rs761385192).
FT                                /FTId=VAR_007206.
FT   VARIANT     251    251       R -> Q. {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071589.
FT   VARIANT     253    253       R -> W (in MPS4A; dbSNP:rs775300515).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024899.
FT   VARIANT     254    254       Y -> C. {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071590.
FT   VARIANT     257    257       A -> T (in MPS4A; severe form;
FT                                dbSNP:rs773283163).
FT                                {ECO:0000269|PubMed:9521421}.
FT                                /FTId=VAR_007207.
FT   VARIANT     259    259       R -> Q (in MPS4A; mild form;
FT                                dbSNP:rs118204442).
FT                                /FTId=VAR_007208.
FT   VARIANT     260    260       E -> D (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024900.
FT   VARIANT     260    260       E -> K. {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071591.
FT   VARIANT     264    264       S -> T (in MPS4A; reduced enzymatic
FT                                activity). {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071592.
FT   VARIANT     279    287       Missing (in MPS4A; mild form).
FT                                /FTId=VAR_007209.
FT   VARIANT     284    284       F -> V (in MPS4A; severe form;
FT                                dbSNP:rs144067930).
FT                                {ECO:0000269|PubMed:9521421}.
FT                                /FTId=VAR_007210.
FT   VARIANT     285    285       Missing (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024901.
FT   VARIANT     287    287       S -> L (in MPS4A; severe form;
FT                                dbSNP:rs770053354).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_007211.
FT   VARIANT     290    290       G -> S (in MPS4A; severe form).
FT                                {ECO:0000269|PubMed:9375852}.
FT                                /FTId=VAR_007212.
FT   VARIANT     291    291       A -> D (in MPS4A; mild form).
FT                                /FTId=VAR_007213.
FT   VARIANT     291    291       A -> T (in MPS4A; severe form;
FT                                dbSNP:rs118204448).
FT                                {ECO:0000269|PubMed:24726177,
FT                                ECO:0000269|PubMed:7633425,
FT                                ECO:0000269|PubMed:7668283}.
FT                                /FTId=VAR_007214.
FT   VARIANT     295    295       S -> F (in MPS4A; mild form;
FT                                dbSNP:rs149239881).
FT                                /FTId=VAR_007215.
FT   VARIANT     301    301       G -> C (in MPS4A; severe form;
FT                                dbSNP:rs118204443).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_007216.
FT   VARIANT     307    307       L -> P (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024902.
FT   VARIANT     309    309       G -> R (in MPS4A; severe form).
FT                                {ECO:0000269|PubMed:9375852}.
FT                                /FTId=VAR_007217.
FT   VARIANT     310    310       K -> N (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024903.
FT   VARIANT     312    312       T -> S (in MPS4A; mild/intermediate/
FT                                severe form; dbSNP:rs118204446).
FT                                {ECO:0000269|PubMed:24726177,
FT                                ECO:0000269|PubMed:9521421}.
FT                                /FTId=VAR_007218.
FT   VARIANT     318    318       M -> R (in MPS4A; severe form;
FT                                dbSNP:rs746756997).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_007219.
FT   VARIANT     325    325       W -> C (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024904.
FT   VARIANT     325    325       Missing (in MPS4A).
FT                                /FTId=VAR_007220.
FT   VARIANT     340    340       G -> D (in MPS4A; dbSNP:rs267606838).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024905.
FT   VARIANT     341    341       S -> R (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024906.
FT   VARIANT     343    343       M -> R (in MPS4A; severe form).
FT                                /FTId=VAR_007221.
FT   VARIANT     344    344       D -> E (in MPS4A).
FT                                /FTId=VAR_007222.
FT   VARIANT     344    344       D -> N (in MPS4A; severe form).
FT                                /FTId=VAR_007223.
FT   VARIANT     345    345       L -> P (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024907.
FT   VARIANT     346    346       F -> L (in MPS4A; severe form).
FT                                /FTId=VAR_007224.
FT   VARIANT     351    351       A -> V (in MPS4A; severe form;
FT                                dbSNP:rs761386453).
FT                                {ECO:0000269|PubMed:9375852}.
FT                                /FTId=VAR_007225.
FT   VARIANT     352    352       L -> P (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024908.
FT   VARIANT     357    357       P -> L (in MPS4A; dbSNP:rs769748679).
FT                                {ECO:0000269|PubMed:16287098,
FT                                ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_024909.
FT   VARIANT     361    361       R -> G (in MPS4A; dbSNP:rs778120439).
FT                                /FTId=VAR_007226.
FT   VARIANT     369    369       L -> P (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024910.
FT   VARIANT     376    376       R -> Q (in MPS4A; severe form;
FT                                dbSNP:rs150734270).
FT                                {ECO:0000269|PubMed:9521421}.
FT                                /FTId=VAR_007227.
FT   VARIANT     380    380       R -> G (in MPS4A; loss of enzymatic
FT                                activity; dbSNP:rs770908172).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071593.
FT   VARIANT     380    380       R -> S (in MPS4A; dbSNP:rs200763834).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024911.
FT   VARIANT     380    380       R -> T (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098,
FT                                ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_024912.
FT   VARIANT     386    386       R -> C (in MPS4A; severe form;
FT                                dbSNP:rs118204437).
FT                                {ECO:0000269|PubMed:24726177,
FT                                ECO:0000269|PubMed:7668283,
FT                                ECO:0000269|PubMed:9375852}.
FT                                /FTId=VAR_007228.
FT   VARIANT     386    386       R -> H (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098,
FT                                ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_024913.
FT   VARIANT     388    388       D -> N (in MPS4A; dbSNP:rs373739301).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024914.
FT   VARIANT     391    391       M -> V (in MPS4A; severe form;
FT                                dbSNP:rs398123429).
FT                                {ECO:0000269|PubMed:24726177,
FT                                ECO:0000269|PubMed:9375852}.
FT                                /FTId=VAR_007229.
FT   VARIANT     392    392       A -> V (in MPS4A; dbSNP:rs398123430).
FT                                {ECO:0000269|PubMed:16287098,
FT                                ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_024915.
FT   VARIANT     393    393       A -> S (in dbSNP:rs2303269).
FT                                {ECO:0000269|PubMed:16287098,
FT                                ECO:0000269|PubMed:9452036}.
FT                                /FTId=VAR_007230.
FT   VARIANT     395    395       L -> P (in MPS4A).
FT                                {ECO:0000269|PubMed:9375852}.
FT                                /FTId=VAR_007231.
FT   VARIANT     395    395       L -> V (in MPS4A; severe form).
FT                                {ECO:0000269|PubMed:9521421}.
FT                                /FTId=VAR_007232.
FT   VARIANT     398    398       H -> D (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024916.
FT   VARIANT     401    401       H -> Y (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024917.
FT   VARIANT     403    404       Missing (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024918.
FT   VARIANT     407    407       N -> H (in MPS4A; dbSNP:rs749578474).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_007233.
FT   VARIANT     409    409       W -> S (in MPS4A; associated with M-67 in
FT                                a patient).
FT                                /FTId=VAR_007234.
FT   VARIANT     415    415       G -> V (in MPS4A; loss of enzymatic
FT                                activity). {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071594.
FT   VARIANT     416    416       I -> T (in MPS4A; reduced enzymatic
FT                                activity; dbSNP:rs142822371).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071595.
FT   VARIANT     420    420       P -> R (in MPS4A; reduced enzymatic
FT                                activity). {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071596.
FT   VARIANT     450    450       E -> V (in MPS4A; severe form).
FT                                /FTId=VAR_007235.
FT   VARIANT     452    452       F -> I (in MPS4A; dbSNP:rs398123432).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024919.
FT   VARIANT     459    459       A -> V (in dbSNP:rs114703967).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_007236.
FT   VARIANT     470    470       S -> P (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024920.
FT   VARIANT     484    484       P -> S (in MPS4A).
FT                                {ECO:0000269|PubMed:16287098}.
FT                                /FTId=VAR_024921.
FT   VARIANT     487    487       N -> S (in MPS4A; dbSNP:rs118204440).
FT                                {ECO:0000269|PubMed:7581409,
FT                                ECO:0000269|PubMed:7668283}.
FT                                /FTId=VAR_007237.
FT   VARIANT     488    488       V -> M (in dbSNP:rs78127134).
FT                                {ECO:0000269|PubMed:16287098,
FT                                ECO:0000269|PubMed:9452036}.
FT                                /FTId=VAR_007238.
FT   VARIANT     492    492       A -> T (in MPS4A; reduced enzymatic
FT                                activity; dbSNP:rs760300454).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071597.
FT   VARIANT     494    494       M -> V (in MPS4A; severe form).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_007239.
FT   VARIANT     495    495       N -> K. {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071598.
FT   VARIANT     500    500       G -> S (in MPS4A; reduced enzymatic
FT                                activity). {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071599.
FT   VARIANT     507    507       C -> F (in MPS4A; dbSNP:rs398123433).
FT                                {ECO:0000269|PubMed:24726177}.
FT                                /FTId=VAR_071600.
FT   VARIANT     510    510       P -> T (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036493.
FT   STRAND       32     40       {ECO:0000244|PDB:4FDI}.
FT   HELIX        47     49       {ECO:0000244|PDB:4FDI}.
FT   HELIX        57     64       {ECO:0000244|PDB:4FDI}.
FT   STRAND       66     68       {ECO:0000244|PDB:4FDI}.
FT   STRAND       70     73       {ECO:0000244|PDB:4FDI}.
FT   STRAND       75     78       {ECO:0000244|PDB:4FDI}.
FT   HELIX        79     88       {ECO:0000244|PDB:4FDI}.
FT   HELIX        92     95       {ECO:0000244|PDB:4FDI}.
FT   HELIX       124    128       {ECO:0000244|PDB:4FDI}.
FT   HELIX       129    131       {ECO:0000244|PDB:4FDI}.
FT   STRAND      134    139       {ECO:0000244|PDB:4FDI}.
FT   HELIX       147    149       {ECO:0000244|PDB:4FDI}.
FT   HELIX       151    153       {ECO:0000244|PDB:4FDI}.
FT   STRAND      157    161       {ECO:0000244|PDB:4FDI}.
FT   STRAND      172    175       {ECO:0000244|PDB:4FDI}.
FT   STRAND      179    182       {ECO:0000244|PDB:4FDI}.
FT   STRAND      185    190       {ECO:0000244|PDB:4FDI}.
FT   TURN        191    193       {ECO:0000244|PDB:4FDI}.
FT   TURN        198    200       {ECO:0000244|PDB:4FDI}.
FT   HELIX       205    220       {ECO:0000244|PDB:4FDI}.
FT   TURN        221    223       {ECO:0000244|PDB:4FDI}.
FT   STRAND      226    231       {ECO:0000244|PDB:4FDI}.
FT   STRAND      236    238       {ECO:0000244|PDB:4FDI}.
FT   HELIX       243    245       {ECO:0000244|PDB:4FDI}.
FT   HELIX       252    274       {ECO:0000244|PDB:4FDI}.
FT   HELIX       278    280       {ECO:0000244|PDB:4FDI}.
FT   STRAND      281    289       {ECO:0000244|PDB:4FDI}.
FT   TURN        296    298       {ECO:0000244|PDB:4FDI}.
FT   STRAND      312    314       {ECO:0000244|PDB:4FDI}.
FT   HELIX       315    318       {ECO:0000244|PDB:4FDI}.
FT   STRAND      322    325       {ECO:0000244|PDB:4FDI}.
FT   TURN        327    329       {ECO:0000244|PDB:4FDI}.
FT   HELIX       344    353       {ECO:0000244|PDB:4FDI}.
FT   STRAND      359    361       {ECO:0000244|PDB:4FDI}.
FT   HELIX       369    374       {ECO:0000244|PDB:4FDI}.
FT   STRAND      382    386       {ECO:0000244|PDB:4FDI}.
FT   STRAND      389    395       {ECO:0000244|PDB:4FDI}.
FT   STRAND      398    404       {ECO:0000244|PDB:4FDI}.
FT   HELIX       409    413       {ECO:0000244|PDB:4FDI}.
FT   TURN        425    427       {ECO:0000244|PDB:4FDI}.
FT   STRAND      436    438       {ECO:0000244|PDB:4FDI}.
FT   STRAND      440    443       {ECO:0000244|PDB:4FDI}.
FT   TURN        444    446       {ECO:0000244|PDB:4FDI}.
FT   HELIX       459    477       {ECO:0000244|PDB:4FDI}.
FT   STRAND      485    489       {ECO:0000244|PDB:4FDI}.
FT   HELIX       491    493       {ECO:0000244|PDB:4FDI}.
FT   STRAND      494    497       {ECO:0000244|PDB:4FDI}.
FT   HELIX       501    504       {ECO:0000244|PDB:4FDI}.
SQ   SEQUENCE   522 AA;  58026 MW;  1D086E528AAAE949 CRC64;
     MAAVVAATRW WQLLLVLSAA GMGASGAPQP PNILLLLMDD MGWGDLGVYG EPSRETPNLD
     RMAAEGLLFP NFYSANPLCS PSRAALLTGR LPIRNGFYTT NAHARNAYTP QEIVGGIPDS
     EQLLPELLKK AGYVSKIVGK WHLGHRPQFH PLKHGFDEWF GSPNCHFGPY DNKARPNIPV
     YRDWEMVGRY YEEFPINLKT GEANLTQIYL QEALDFIKRQ ARHHPFFLYW AVDATHAPVY
     ASKPFLGTSQ RGRYGDAVRE IDDSIGKILE LLQDLHVADN TFVFFTSDNG AALISAPEQG
     GSNGPFLCGK QTTFEGGMRE PALAWWPGHV TAGQVSHQLG SIMDLFTTSL ALAGLTPPSD
     RAIDGLNLLP TLLQGRLMDR PIFYYRGDTL MAATLGQHKA HFWTWTNSWE NFRQGIDFCP
     GQNVSGVTTH NLEDHTKLPL IFHLGRDPGE RFPLSFASAE YQEALSRITS VVQQHQEALV
     PAQPQLNVCN WAVMNWAPPG CEKLGKCLTP PESIPKKCLW SH
//
